We are live on ! Find out more
BCM

Boone Capital Management Portfolio holdings

AUM $326M
1-Year Est. Return 86.31%
This Fund
S&P 500
This Quarter Est. Return
-9.04%
1 Year Est. Return
+86.31%
3 Year Est. Return
+255.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$214M
AUM Growth
+$18.7M
Cap. Flow
+$33.8M
Cap. Flow %
15.83%
Top 10 Hldgs %
93.61%
Holding
20
New
3
Increased
9
Reduced
–
Closed
8

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$19.4M
2
MOH icon
Molina Healthcare
MOH
+$15.2M
3
BAX icon
Baxter International
BAX
+$15M
4
CI icon
Cigna
CI
+$12.7M
5
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$8.8M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$17.4M
2
OGN icon
Organon & Co
OGN
+$13.9M
3
ABT icon
Abbott
ABT
+$12.3M
4
MDRX
Veradigm Inc. Common Stock
MDRX
+$10.6M
5
APEN
Apollo Endosurgery, Inc.
APEN
+$7.16M

Sector Composition

Rank Sector Weight
1 Healthcare 84.12%
2 Financials 15.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNM icon
1
Unum
UNM
$13.7B
$33.9M 15.88%
857,565
+186,035
+28% +$7.68M
CI icon
2
Cigna
CI
$75.1B
$26.2M 12.27%
102,623
+43,594
+74% +$12.7M
MOH icon
3
Molina Healthcare
MOH
$10.2B
$24.7M 11.57%
92,412
+52,968
+134% +$15.2M
DHR icon
4
Danaher
DHR
$137B
$22.3M 10.45%
99,871
+38,557
+63% +$8.77M
AMGN icon
5
Amgen
AMGN
$207B
$19.1M 8.96%
+79,150
New +$19.4M
ENOV icon
6
Enovis
ENOV
$1.66B
$18.2M 8.51%
339,758
+63,512
+23% +$3.68M
BIIB icon
7
Biogen
BIIB
$30.2B
$16.5M 7.75%
59,522
+17,679
+42% +$4.89M
BAX icon
8
Baxter International
BAX
$13.5B
$14.4M 6.73%
+354,443
New +$15M
ABBV icon
9
AbbVie
ABBV
$450B
$14M 6.57%
88,026
+12,153
+16% +$1.86M
TBRG
10
DELISTED
TruBridge
TBRG
$10.5M 4.94%
349,245
+121,880
+54% +$3.55M
CERE
11
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$7.32M 3.43%
+300,000
New +$8.8M
QTRX icon
12
Quanterix
QTRX
$160M
$6.32M 2.96%
561,144
+70,919
+14% +$906K
ABT icon
13
Abbott
ABT
$182B
– –
-112,106
Closed -$12.3M
AFMD
14
DELISTED
Affimed
AFMD
– –
-286,974
Closed -$3.56M
CABA icon
15
Cabaletta Bio
CABA
$427M
– –
-266,882
Closed -$2.47M
LLY icon
16
Eli Lilly
LLY
$1.02T
– –
-47,448
Closed -$17.4M
OGN icon
17
Organon & Co
OGN
$3.56B
– –
-498,262
Closed -$13.9M
MDRX
18
DELISTED
Veradigm Inc. Common Stock
MDRX
– –
-600,000
Closed -$10.6M
CSII
19
DELISTED
Cardiovascular Systems, Inc.
CSII
– –
-99,157
Closed -$1.35M
APEN
20
DELISTED
Apollo Endosurgery, Inc.
APEN
– –
-718,419
Closed -$7.16M

Similar funds

ISFAN
Investor's Fiduciary Advisor Network Snoqualmie, Washington $326M AUM 19.7% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
AFA
Alpha Financial Advisors Charlotte, North Carolina $326M AUM 15.49% 1-Year Est. Return
ECH
ER Collective Holdings Washington, District of Columbia $326M AUM
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
MVM
Menlo Ventures Management Menlo Park, California $327M AUM
CCG
Ceeto Capital Group Coral Gables, Florida $326M AUM 24.81% 1-Year Est. Return
TC
TFR Capital Plano, Texas $326M AUM 24.24% 1-Year Est. Return

Boone Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Boone Capital Management held 20 positions worth $214M, up 9.6% from $195M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Boone Capital Management deployed $33.8M of net new capital in Q1 2023, opening 3 new positions and adding to 9 existing holdings. Its largest new stake was Amgen: 79,150 shares worth $19.1M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 85% a quarter earlier, followed by Financials.

On the sell side, the most notable exit was Eli Lilly, an estimated $17.4M sold.

  • Boone Capital Management's largest Q1 2023 buy was Amgen: 79,150 shares worth $19.1M.
  • Boone Capital Management added most to Molina Healthcare in Q1 2023, an estimated $15.2M increase.
  • Boone Capital Management fully exited Eli Lilly in Q1 2023, selling an estimated $17.4M.
  • Boone Capital Management's ten largest holdings make up 94% of its $214M portfolio in Q1 2023.
  • Boone Capital Management opened 3 new positions and closed 8 in Q1 2023.
  • Boone Capital Management's portfolio value rose 9.6% quarter-over-quarter to $214M.

Based on Boone Capital Management's 13F filing for Q1 2023, filed 15 May 2023.